Related Experiment Video
Updated: Oct 2, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Rapid cessation of acute diarrhea using a novel solution of bioactive polyphenols: a randomized trial in Nicaraguan
Arthur Dover1, Neema Patel2, K T Park3
1Aptos Travel Clinic , Aptos, CA , USA.
Insights
Bioactive polyphenols in solution LX significantly reduced diarrhea duration and frequency in children. This novel supplement, when added to oral rehydration solution (ORS), offers a faster recovery from acute diarrhea compared to ORS alone.
Area of Science:
- Pediatric Gastroenterology
- Nutritional Science
- Pharmacology
Background:
- Oral rehydration solution (ORS) is the standard treatment for acute diarrhea in developing nations.
- Plant-derived products show potential in improving intestinal function.
- A supplement that accelerates diarrhea resolution alongside ORS would be a significant advancement.
Purpose of the Study:
- To evaluate the efficacy of bioactive polyphenols in solution (LX) for restoring normal bowel function in pediatric acute diarrhea.
- To determine if LX enhances the effectiveness of ORS in treating pediatric diarrhea.
Main Methods:
- A randomized, double-blind, placebo-controlled, cross-over study involving 61 pediatric patients with acute diarrhea.
- Participants received either ORS + LX or ORS + water on alternating days.
- Key metrics included time to diarrhea resolution and number of bowel movements.
Main Results:
- Diarrhea resolved significantly faster in the study arm (3.1 hours) compared to the control arm (9.2 hours) on day 1 (p=0.002).
- 60% of patients in the study arm experienced normal stool consistency after the first bowel movement post-consumption of LX.
- Patients receiving LX showed a significant reduction in bowel movement frequency from day 1 to day 2 (p=0.0001).
Conclusions:
- The novel polyphenol solution (LX) significantly reduced bowel movement frequency.
- LX demonstrated rapid normalization of stool consistency in pediatric patients with acute diarrhea.
- No adverse events were reported, suggesting a safe and effective therapeutic option.
Abstract:
Goal. We assessed the effectiveness of bioactive polyphenols contained in solution (LX) to restore normal bowel function in pediatric patients with acute diarrhea. Background. While providing oral rehydration solution (ORS) is standard treatment for diarrhea in developing countries, plant-derived products have been shown to positively affect intestinal function. If a supplement to ORS resolves diarrhea more rapidly than ORS alone, it is an improvement to current care. Study. In a randomized, double-blind, placebo-controlled cross-over study, 61 pediatric patients with uncontrolled diarrhea were randomized to receive either ORS + LX on day 1 and then ORS + water on day 2 (study arm) or ORS + water on day 1 and then ORS + LX on day 2 (control arm). Time to resolution and number of bowel movements were recorded. Results. On day 1, the mean time to diarrhea resolution was 3.1 h (study arm) versus 9.2 h (control arm) (p = 0.002). In the study arm, 60% of patients had normal stool at their first bowel movement after consumption of the phenolic redoxigen solution (LX). On day 2, patients in the study arm continued to have normal stool while patients in the control arm achieved normal stool within 24 h after consuming the test solution. Patients in the control arm experienced a reduction in the mean number of bowel movements from day 1 to day 2 after consuming the test solution (p = 0.0001). No adverse events were observed. Conclusions. Significant decreases in bowel movement frequency and rapid normalization of stool consistency were observed with consumption of this novel solution.
More Related Videos
07:38Author Spotlight: Advancing Antidiarrheal Research with the Drosophila Model
Published on: November 17, 2023
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion